Pharmabiz58m
Sobi & Apellis Pharma announces EMA validates indication extension application for Aspaveli for treatment of C3G and primary IC-MPGN
Stockholm, Sweden Saturday, February 22, 2025, 09:00 Hrs [IST] ...
Pharmabiz1h
DGTR postpones oral hearing in anti-dumping probe on resorcinol imports from China and Japan
DGTR postpones oral hearing in anti-dumping probe on resorcinol imports from China and Japan: Shardul Nautiyal, Mumbai Saturday, February 22, 2025, 08:00 Hrs [IST] The Directorate ...
Pharmabiz1h
Pharma Literati launches course on ‘Patenting in Herbal, Ayush and Nutraceutical products’
Customized to the needs of students, researchers, academicians and industry professionals, Pharma Literati has recently launched India’s first course on ‘Patenting in Herbal, Ayush and Nutraceutical ...
Pharmabiz1h
BioAsia 2025 to host Global Healthcare Leaders to drive transformative innovation
BioAsia 2025 to host Global Healthcare Leaders to drive transformative innovation: Our Bureau, Mumbai Saturday, February 22, 2025, 08:00 Hrs [IST] Bio Asia, Asia's premier life sc ...
Pharmabiz1h
India embarks on advanced research to thwart rising encephalitis cases
India embarks on advanced research to thwart rising encephalitis cases: Nandita Vijayasimha, Bengaluru Saturday, February 22, 2025, 08:00 Hrs [IST] India is intensifying research ...
Pharmabiz1h
TN APTI to hold seminar on ‘Pioneering Pharmacy Profession’ at Dhanalakshmi University today
TN APTI to hold seminar on ‘Pioneering Pharmacy Profession’ at Dhanalakshmi University today: Peethaambaran Kunnathoor, Chennai Saturday, February 22, 2025, 08:00 Hrs [IST] In ...
Pharmabiz17h
Recce Pharma announces positive clinical data from phase II trial of RECCE 327 gel in acute bacterial skin & skin structure infections
Recce Pharma announces positive clinical data from phase II trial of RECCE 327 gel in acute bacterial skin & skin structure infections: Sydney Friday, February 21, 2025, 16:00 Hrs ...
Pharmabiz23h
Chugai obtains Japanese regulatory approval for Tecentriq for additional indication of alveolar soft part sarcoma, an ultra-rare disease
Chugai obtains Japanese regulatory approval for Tecentriq for additional indication of alveolar soft part sarcoma, an ultra-rare disease: Tokyo Friday, February 21, 2025, 10:00 Hr ...
Pharmabiz15h
Anixa Biosciences receives approval of protocol amendment for ovarian cancer CAR-T clinical trial
Anixa Biosciences receives approval of protocol amendment for ovarian cancer CAR-T clinical trial: San Jose, California Friday, February 21, 2025, 18:00 Hrs [IST] Anixa Bioscience ...
Pharmabiz19h
Aidoc receives US FDA clearance for first foundation model-powered clinical artificial intelligence solution
Aidoc receives US FDA clearance for first foundation model-powered clinical artificial intelligence solution: New York Friday, February 21, 2025, 14:00 Hrs [IST] Aidoc, a global l ...
Pharmabiz20h
Septerna discontinues phase 1 clinical trial of SEP-786; plans to advance next-generation oral small molecule PTH1R agonist
Septerna discontinues phase 1 clinical trial of SEP-786; plans to advance next-generation oral small molecule PTH1R agonist: South San Francisco, California Friday, February 21, 2 ...
Pharmabiz18h
Ono Pharmaceutical’s vimseltinib to treat tenosynovial giant cell tumour gets US FDA approval
Ono Pharmaceutical’s vimseltinib to treat tenosynovial giant cell tumour gets US FDA approval: Osaka Friday, February 21, 2025, 15:00 Hrs [IST] Ono Pharmaceutical, one of the la ...